How fast does semaglutide work for weight loss — and what should you actually expect?

Appetite suppression can begin within the first week, but most people see noticeable scale movement between weeks four and eight.
In the STEP 1 clinical trial, participants using semaglutide 2.4mg lost an average of around 15% of body weight over 68 weeks, published in the New England Journal of Medicine.
The titration schedule (starting at 0.25mg and rising gradually) means the full therapeutic effect builds over several months, not days.
Slower early progress does not mean the treatment isn't working; the gradual dose increase is deliberate and designed to reduce side effects.

Semaglutide begins reducing appetite within days of the first injection, but meaningful weight loss typically shows up over weeks to months, not overnight. Most people notice the scales moving noticeably by weeks four to eight, with the largest reductions accumulating across the full treatment period. These are prescription-only medicines; a clinician assesses suitability before any treatment begins. The pattern of how quickly Wegovy works for weight loss follows a broadly predictable arc, though the pace differs between individuals depending on starting weight, dose, diet and other health factors.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The real timeline: what changes early, what takes longer, and what the trials show

The biggest misconception: semaglutide is not a fast-acting drug — and that's the design

Ask most people what they expect from a weight-loss injection and they'll say something like: 'I heard you stop feeling hungry almost straight away and the weight falls off.' The first part is partly right. The second is where expectations come unstuck, and getting this wrong is genuinely the most common reason people feel they're failing when they're actually on track.

Semaglutide works as a GLP-1 receptor agonist, slowing gastric emptying and signalling fullness to the brain. That appetite shift can start within the first week at 0.25mg. What doesn't follow immediately is significant weight loss. The starting dose is there to let your body adjust, not to produce the maximum effect. As doses step up over months (through 0.5mg, 1mg, 1.7mg and up to 2.4mg (or the newer 7.2mg)) the therapeutic effect compounds. If you're curious about how fast semaglutide works at each stage of the titration, the honest answer is that it builds gradually rather than arriving all at once.

The full timeline for semaglutide to work runs across the entire treatment period, which in clinical trials was 68 weeks. Expecting dramatic results in the first fortnight is the wrong frame. Being disappointed at week three is normal, and it's not a signal to stop.

What the STEP 1 trial actually shows, and how to read the numbers honestly

The most-cited figure from semaglutide's pivotal trial is around 15% average body weight reduction over 68 weeks at the 2.4mg maintenance dose, published in STEP 1 in the New England Journal of Medicine. That number is real and it's clinically significant. But read it carefully: it's an average, it's 68 weeks, and it was achieved alongside a reduced-calorie diet and increased physical activity.

What the trial also shows is that the curve isn't linear. Weight loss accelerates once participants reach higher doses and then levels off as the body reaches a new equilibrium. Many people lose a modest amount in the first eight weeks, then see a more pronounced shift between months three and six. By month twelve, results tend to stabilise.

One quick habit worth building: note your weight at the same time of day, on the same day each week, rather than stepping on the scales every morning. Daily fluctuations of one to two kilograms from food, water and hormonal changes are normal and tell you very little. A weekly reading gives a cleaner signal.

For context on how the titration steps affect the trajectory, the broader picture of how GLP-1 medicines like semaglutide build their effect is worth understanding before you start.

Why individual results vary, and what actually influences the pace

Two people on the same dose, following the same lifestyle guidance, will not always lose weight at the same speed. That's not a flaw in the medicine; it reflects genuine biological variation. Several factors shape how quickly semaglutide works for any one person.

Starting weight matters. Someone with a higher starting BMI often sees a larger absolute number shift early on, even if the percentage is similar. Insulin resistance, previous dieting history, gut motility and how someone tolerates the titration steps all play a role. Gastrointestinal side effects (nausea, changes in appetite, occasional loose stools) are common in the early weeks and, if significant, sometimes lead the prescriber to hold a dose rather than increase it on schedule. That's good clinical practice, not a setback.

Diet composition during treatment also matters more than many people expect. Semaglutide reduces appetite, but it doesn't override a high-calorie diet. NHS guidance on semaglutide emphasises using the medicine alongside dietary changes and physical activity, the clinical trials were designed exactly that way.

Patients who are transferring to semaglutide from another treatment, or who are considering switching doses, should expect their prescriber to re-evaluate their history before any change. The full picture of how Wegovy works as a treatment gives useful background on what the medicine is licensed for and the population it's studied in.

Practical expectations: what a realistic first six months looks like

Weeks one to four: appetite shifts, sometimes noticeably, sometimes subtly. Scale movement is often modest, perhaps one to three kilograms. This is normal. The dose is still low.

Months two to four: most people reach 1mg or 1.7mg during this window and start to see more consistent progress. This is often where the 'it's actually working' moment arrives. Weight loss of five to ten percent from starting weight across this phase is a reasonable expectation, though not a guarantee.

Months four to twelve: the cumulative effect builds. Reaching and staying at the 2.4mg maintenance dose (or higher if clinically appropriate) is where the STEP 1 trial's headline figures were generated. Progress may slow before it plateaus, that's the normal pharmacological picture, not a sign the medicine has stopped working.

If you're weighing up what treatment might look like for you, a free consultation is the right starting point. Our prescribers review every application personally and can give you a realistic picture of what to expect based on your health and history. Start your free consultation and get an honest clinical view the same day.

For detail on how pricing compares across the treatment period, the Wegovy pricing page covers what a private prescription typically involves.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions